It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Details
Title
Author Correction: Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity
Author
Sant’Anna, Ricardo 1 ; Gallego, Pablo 1 ; Robinson, Lei Z. 2 ; Pereira-Henriques, Alda 3 ; Ferreira, Nelson 3 ; Pinheiro, Francisca 1 ; Esperante, Sebastian 1 ; Pallares, Irantzu 1 ; Huertas, Oscar 4 ; Almeida, Maria Rosário 3 ; Reixach, Natàlia 2 ; Insa, Raul 5 ; Velazquez-Campoy, Adrian 6 ; Reverter, David 1 ; Reig, Núria 4 ; Ventura, Salvador 1
1 Universitat Autònoma de Barcelona, Bellaterra, Institut de Biotecnologia i Biomedicina and Departament de Bioquímica i Biologia Molecular, Barcelona, Spain (GRID:grid.7080.f) (ISNI:0000 0001 2296 0625)
2 The Scripps Research Institute, Molecular and Experimental Medicine Department, La Jolla, USA (GRID:grid.214007.0) (ISNI:0000000122199231)
3 Universidade do Porto, Molecular Neurobiology, IBMC- Instituto de Biologia Molecular e Celular i3S - Instituto de Investigação e Inovação em Saúde and ICBAS- Instituto de Ciências Biomédicas de Abel Salazar, Porto, Portugal (GRID:grid.5808.5) (ISNI:0000 0001 1503 7226)
4 SOM-Biotech, Barcelona, Spain (GRID:grid.7080.f)
5 SOM-Biotech, Barcelona, Spain (GRID:grid.214007.0)
6 Universidad de Zaragoza, Institute of Biocomputation and Physics of Complex Systems (BIFI), Joint Unit IQFR-CSIC-BIFI, Zaragoza, Spain (GRID:grid.11205.37) (ISNI:0000 0001 2152 8769); University of Zaragoza, Department of Biochemistry and Molecular and Cell Biology, Zaragoza, Spain (GRID:grid.11205.37) (ISNI:0000 0001 2152 8769); Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain (GRID:grid.488737.7) (ISNI:0000000463436020); Fundación ARAID, Government of Aragón, Zaragoza, Spain (GRID:grid.418268.1) (ISNI:0000 0004 0546 8112)
1 Universitat Autònoma de Barcelona, Bellaterra, Institut de Biotecnologia i Biomedicina and Departament de Bioquímica i Biologia Molecular, Barcelona, Spain (GRID:grid.7080.f) (ISNI:0000 0001 2296 0625)
2 The Scripps Research Institute, Molecular and Experimental Medicine Department, La Jolla, USA (GRID:grid.214007.0) (ISNI:0000000122199231)
3 Universidade do Porto, Molecular Neurobiology, IBMC- Instituto de Biologia Molecular e Celular i3S - Instituto de Investigação e Inovação em Saúde and ICBAS- Instituto de Ciências Biomédicas de Abel Salazar, Porto, Portugal (GRID:grid.5808.5) (ISNI:0000 0001 1503 7226)
4 SOM-Biotech, Barcelona, Spain (GRID:grid.7080.f)
5 SOM-Biotech, Barcelona, Spain (GRID:grid.214007.0)
6 Universidad de Zaragoza, Institute of Biocomputation and Physics of Complex Systems (BIFI), Joint Unit IQFR-CSIC-BIFI, Zaragoza, Spain (GRID:grid.11205.37) (ISNI:0000 0001 2152 8769); University of Zaragoza, Department of Biochemistry and Molecular and Cell Biology, Zaragoza, Spain (GRID:grid.11205.37) (ISNI:0000 0001 2152 8769); Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain (GRID:grid.488737.7) (ISNI:0000000463436020); Fundación ARAID, Government of Aragón, Zaragoza, Spain (GRID:grid.418268.1) (ISNI:0000 0004 0546 8112)
Pages
582
Publication year
2023
Publication date
2023
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2772195036
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.